Pertuzumab: encouraging early results in stage IV breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 353-360

Adis International

Access to resources Recommend Favorite

Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer

By Simoens Steven  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 181-185

Adis International

Access to resources Recommend Favorite

Complete Estrogen Blockade for the Treatment of Metastatic and Early Stage Breast Cancer

By Michaud L.B.   Buzdar A.U.  

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 261-271

Adis International

Access to resources Recommend Favorite

Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

By Reimer Toralf   Gerber Bernd  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 791-800

Adis International

Access to resources Recommend Favorite

Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing

By Simoens Steven  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 807-809

Adis International

Access to resources Recommend Favorite